Skip to content

13F-HR filed by Venrock Adviser, LLC

Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:49:16 UTC, with 34 holding rows worth $2,058,215,412.

Accession
0001615982-26-000019
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 34 entries on the cover page, a total value of $2,058,215,412 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,058,215,412 with VALUE read as dollars as filed, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ORUKA THERAPEUTICS INC COM687604108Stock4,148,428$345,522,568dollars as filed
ERASCA INC COM29479A108Stock20,089,932$294,518,403dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW2,485,448$221,279,435dollars as filed
KORSANA BIOSCIENCES INC23255M303COMMON STOCK4,549,585$145,586,720dollars as filed
SAVARA INC805111101COM19,568,534$100,973,635dollars as filed
OCULAR THERAPEUTIX INC67576A100COM10,346,926$79,360,922dollars as filed
DAMORA THERAPEUTICS INCG2646Y104COMM STK3,603,595$76,684,502dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM822,020$72,378,861dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM3,257,917$67,080,511dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK3,041,719$58,035,999dollars as filed
COGENT BIOSCIENCES INC19240Q201COM1,642,166$52,582,155dollars as filed
Adlai Nortye00704R109SPONSORED ADS3,212,731$51,403,696dollars as filed
JADE BIOSCIENCES INC008064206COM NEW3,220,364$45,246,114dollars as filed
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK5,502,064$44,511,698dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock1,545,616$42,009,843dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM2,944,056$39,656,434dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock2,173,913$35,021,738dollars as filed
ADARx Pharmaceuticals, Inc.00654F105Common Stock, par value $0.0001 per share1,625,793$32,418,312dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK2,133,734$31,131,179dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK7,445,050$28,067,839dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK6,434,990$26,769,558dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK7,644,072$22,167,809dollars as filed
CULLINAN THERAPEUTICS INC230031106COM1,379,965$21,182,463dollars as filed
SURROZEN INC86889P208COMMON STOCK632,931$20,367,720dollars as filed
PARABILIS MEDICINES INC COM698955101Stock625,000$20,181,250dollars as filed
ARVINAS INC04335A105COM1,952,533$15,102,843dollars as filed
CENTURY THERAPEUTICS INC15673T100COM8,695,652$14,869,565dollars as filed
ENTERA BIO LTDM40527109SHS5,106,337$14,859,441dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM2,043,596$14,550,404dollars as filed
ALTO NEUROSCIENCE INC COM SHS02157Q109Stock500,000$12,765,000dollars as filed
KORRO BIO INC500946108COMMON STOCK443,431$4,394,401dollars as filed
TCGX ACQUISITION CORPG8708J109COM300,000$3,753,000dollars as filed
RESEARCH ALLIANCE CORP IVG75228109CL A ORD SHS300,000$3,600,000dollars as filed
INMED PHARMACEUTICALS INC457637700COM NEW133,378$181,394dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001615982-26-000019this filing2026-11-16